As of October 21, the Health Ministry reported an additional 4,267 new cases, bringing the total number of infections to 373,109 with 12,857 deaths. Cases have plateaued in the last month after reaching a daily high of 4,823 new infections on September 253. Indonesia currently has 376 laboratories with a combined testing capacity of 40,000 specimens per day to serve the population of 260 million people. The government has also taken some significant steps, capping the cost of COVID tests, setting a goal of obtaining 670,000 vials of remdesivir by the end of 20204, and have set up the National Economic Recovery Task Force with a budget of IDR 695.2 trillion budget, the majority spent on social protection programs. Some businesses are able to open to 25% but high-risk locations like karaoke bars and night clubs remain closed with contact tracing being implemented among all open businesses5.
Indonesia and Singapore have also implemented a Reciprocal Green Lane (RGL) agreement that allows qualifying essential businesspeople to travel back and forth. Only citizens of Singapore and Indonesia are eligible to apply for this program5.
While the government’s hospital budget has doubled in 2020 from IDR 9 trillion (US$613.5 million) to IDR 18 Trillion (US$1.2 billion), most of the budget will be spent on PPE and other pandemic specific products. When combined with the APBD (Regional Revenue Expenditure Budget), and private budgets, the total expenditure on medical equipment in Indonesia averages around IDR 50 trillion (US$3.4 billion) per year. Even though upgrading hospitals and the healthcare infrastructure remain a top priority for the Indonesian government; upgrades, elective surgeries, and dentist offices will likely decline until COVID pandemic can be addressed. As a result, medical equipment transactions are only at about half of what they would be under normal conditions this year.
Who’s Registering Products During COVID
The Ministry of Health has provided priority pathways and accelerated One Day Service (ODS) services for licensing medical devices used for Covid-19 management. During the period January 1, 2020 – June 30, 2020, there was a significant increase in product approval for medical device and Household Health Supplies (PKRT) due to this relaxation, along with PPE. Apart from domestic products, the impact of this relaxation has also increased the number of imported products being approved. Many of the imported products include medical devices used to carry out diagnostic tests for Covid-19 patients such as PCR devices, reagents, and swab kits.
The below table is a snapshot of products that have been approved in the first half of this year compared to last year7.
Table 1. Personal Protective Equipment Approval
|No||Product||Domestic products||Imported products|
Table 2. Hand Sanitizer and Disinfectant Approval
|No||Product||Domestic Products||Imported Products|
If you would like to learn more about registered products in Indonesia, support evaluating your product’s potential in the market, or want to learn more about the registration process, please contact Asia Actual today for support.